Indian industry interaction with G20 Health Working Group delegates," Union Health Minister Mansukh Mandaviya stated that healthcare is more than simply a sector; it is a mission.
To provide every citizen of this great nation the highest quality quality healthcare is our mission. said Mandaviya, medical devices and pharmaceutical companies are an essential partner to accomplish this goal.
As the drug minister, India's pharmaceutical sector is a recognised global hub and helps tremendously to improving health outcomes by acting as a trusted source of affordable, high-quality drugs.
By providing over 60% of the the world's vaccine supply and 20% to 22% of the generic drug exports, India, he added, has significantly enhanced accessibility on a global basis.
"In recent years, our system of healthcare witnessed significant modifications. We are advancing away from volume-based approaches towards towards. Quality, accessibility, and affordability of healthcare are the key elements of a value-based leadership model, he said.
Budi G. Sadikin and Dr. Ernst Kuipers, the health ministers for Indonesia and the Netherlands, were among those who were at the manufacturing dedication meeting.
Indonesia's health minister, Sadikin, praised and thanked India for donating medicines and active pharmaceutical ingredients (API) for Indonesia during the pandemic.
"For saving lives, I thank India and Health Minister Dr. Mansukh Mandaviya. We got a trip and came to India to find of the drugs, he said.
The G20 Health Minister's Meeting focused on the three main priorities of the G20 Health Track: strengthening pharmaceutical sector cooperation with a focus on access and availability to safe, effective, quality, affordable medical countermeasures (vaccines, medication, and diagnostics); and innovations in digital health. prevention, preparedness, and response to health emergencies with a focus on antimicrobial resistance and the One Health framework.